Sign in

CIK 0001453687

  • Non-accelerated filer
  • Smaller reporting company

Cartesian Therapeutics, Inc.

Sign in to watch
Ticker
RNAC
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 301-348-8698
Business address
7495 NEW HORIZON WAY, FREDERICK, MD, 21703
Former names
SELECTA BIOSCIENCES INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2025-01-10 Jewell Christopher M Chief Scientific Officer Exercise or conversion +9,000 $3.23 $29K 62,490
2025-01-10 Jewell Christopher M Chief Scientific Officer Exercise or conversion · Stock Option (Right to Buy) −9,000 67,432
2025-01-06 Jewell Christopher M Chief Scientific Officer Sale −1,286 $16.83 $22K 53,490
2025-01-03 Jewell Christopher M Chief Scientific Officer Sale −1,264 $16.72 $21K 54,776
2025-01-02 Jewell Christopher M Chief Scientific Officer Grant or award +16,100 56,040
2025-01-02 Jewell Christopher M Chief Scientific Officer Grant or award · Employee Stock Option (right to buy) +47,400 47,400
2024-11-20 Jewell Christopher M Chief Scientific Officer Exercise or conversion +14,000 $3.23 $45K 39,940
2024-11-20 Jewell Christopher M Chief Scientific Officer Exercise or conversion · Stock Option (Right to Buy) −14,000 76,432
2024-11-15 Jewell Christopher M Chief Scientific Officer Exercise or conversion +16,065 $3.23 $52K 42,005
2024-11-15 Jewell Christopher M Chief Scientific Officer Sale −16,065 $17.06 $274K 25,940
2024-11-15 Jewell Christopher M Chief Scientific Officer Exercise or conversion · Stock Option (Right to Buy) −16,065 90,432
2024-11-14 Jewell Christopher M Chief Scientific Officer Exercise or conversion +36,050 $3.23 $116K 61,990
2024-11-14 Jewell Christopher M Chief Scientific Officer Sale −18,550 $16.34 $303K 43,440
2024-11-14 Jewell Christopher M Chief Scientific Officer Sale −17,500 $17.02 $298K 25,940
2024-11-14 Jewell Christopher M Chief Scientific Officer Exercise or conversion · Stock Option (Right to Buy) −36,050 106,497
2024-04-08 Jewell Christopher M Chief Scientific Officer Exercise or conversion · Stock Option (Right to Buy) −4,276.45 0
2024-04-08 Jewell Christopher M Chief Scientific Officer Exercise or conversion · Stock Option (Right to Buy) +142,547 142,547
2024-01-02 Jewell Christopher M Chief Scientific Officer Grant or award +778,200 778,200
2024-01-02 Jewell Christopher M Chief Scientific Officer Grant or award · Employee Stock Option (right to buy) +998,000 998,000
2023-11-13 Jewell Christopher M Chief Scientific Officer Grant or award · Stock Option (Right to Buy) +4,276.45 4,276.45

Page 1 of 1 · 20 trades